1. Home
  2. LIVN vs MQ Comparison

LIVN vs MQ Comparison

Compare LIVN & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVN
  • MQ
  • Stock Information
  • Founded
  • LIVN 1987
  • MQ 2010
  • Country
  • LIVN United Kingdom
  • MQ United States
  • Employees
  • LIVN N/A
  • MQ N/A
  • Industry
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MQ Computer Software: Prepackaged Software
  • Sector
  • LIVN Health Care
  • MQ Technology
  • Exchange
  • LIVN Nasdaq
  • MQ Nasdaq
  • Market Cap
  • LIVN 2.2B
  • MQ 1.9B
  • IPO Year
  • LIVN 1993
  • MQ 2021
  • Fundamental
  • Price
  • LIVN $39.13
  • MQ $4.19
  • Analyst Decision
  • LIVN Buy
  • MQ Hold
  • Analyst Count
  • LIVN 7
  • MQ 14
  • Target Price
  • LIVN $60.29
  • MQ $5.14
  • AVG Volume (30 Days)
  • LIVN 750.6K
  • MQ 8.5M
  • Earning Date
  • LIVN 05-07-2025
  • MQ 05-07-2025
  • Dividend Yield
  • LIVN N/A
  • MQ N/A
  • EPS Growth
  • LIVN 262.50
  • MQ N/A
  • EPS
  • LIVN 1.16
  • MQ 0.05
  • Revenue
  • LIVN $1,253,437,000.00
  • MQ $506,995,000.00
  • Revenue This Year
  • LIVN $5.47
  • MQ $20.89
  • Revenue Next Year
  • LIVN $5.30
  • MQ $21.23
  • P/E Ratio
  • LIVN $33.73
  • MQ $79.39
  • Revenue Growth
  • LIVN 8.66
  • MQ N/A
  • 52 Week Low
  • LIVN $36.85
  • MQ $3.37
  • 52 Week High
  • LIVN $64.48
  • MQ $6.25
  • Technical
  • Relative Strength Index (RSI)
  • LIVN 38.77
  • MQ 50.82
  • Support Level
  • LIVN $39.16
  • MQ $4.36
  • Resistance Level
  • LIVN $40.30
  • MQ $4.59
  • Average True Range (ATR)
  • LIVN 1.09
  • MQ 0.19
  • MACD
  • LIVN 0.25
  • MQ -0.01
  • Stochastic Oscillator
  • LIVN 44.59
  • MQ 45.97

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Share on Social Networks: